ERT

Avance Clinical and Medidata Celebrate Strategic Partnership and Inhouse Expert Accreditation Milestones

Retrieved on: 
Friday, February 26, 2021
Health sciences, Medical research, Clinical data management, Clinical trials, Clinical research, Medidata Solutions, Avance, Clinical trial management system, ERT

ADELAIDE, AU, Feb 26, 2021 - (ACN Newswire) - The leading Australian CRO for biotechs, and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner, Avance Clinical continues to celebrate their strategic partnership with Medidata, and the accreditation of seven Medidata inhouse experts.

Key Points: 
  • ADELAIDE, AU, Feb 26, 2021 - (ACN Newswire) - The leading Australian CRO for biotechs, and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner, Avance Clinical continues to celebrate their strategic partnership with Medidata, and the accreditation of seven Medidata inhouse experts.
  • "Our seven Avance Clinical accredited Medidata experts lead our efforts, and it makes a real difference for our clients having them inhouse rather than as external consultants."
  • https://www.avancecro.com/eclinical-solutions/
    Australia's Avance Clinical has more than 20-years of experience and is now one of Australia's leading Contract Research Organizations.
  • Avance Clinical offers high-quality services in an established clinical trial ecosystem, that includes world-class Investigators and Sites able to access specialized patient groups.

Calyx Offers Scientific Consulting to Optimize Clinical Development

Retrieved on: 
Thursday, February 25, 2021
Contract research organizations, ERT

NOTTINGHAM, United Kingdom, Feb. 25, 2021 /PRNewswire/ -- Calyx , theeClinicaland regulatory solutions and services provider most relied on for solving complex data challenges in clinical research, today announced a scientific consulting program aimed at optimizing imaging processes and outcomes to accelerate the clinical development of new medical treatments.

Key Points: 
  • NOTTINGHAM, United Kingdom, Feb. 25, 2021 /PRNewswire/ -- Calyx , theeClinicaland regulatory solutions and services provider most relied on for solving complex data challenges in clinical research, today announced a scientific consulting program aimed at optimizing imaging processes and outcomes to accelerate the clinical development of new medical treatments.
  • Through Calyx Scientific Consulting, biopharmaceutical researchers can extend the deep and diverse experience of Calyx's highly tenured medical, scientific, and regulatory experts to their own clinical development teams.
  • Having supported over 2,600 imaging studies and 250+ new drug approvals, Calyx consultants are routinely engaged by biopharmaceutical researchers to ensure the scientific integrity and regulatory compliance of their imaging processes during clinical development.
  • Calyx Scientific Consulting delivers a broad range of services to meet the specific needs of new product development, including:
    Click here for additional information on Calyx's Scientific Consulting Program.

ERT Survey Reveals Challenges and Innovations within CNS Clinical Trials

Retrieved on: 
Thursday, February 25, 2021
Distributed computing architecture, Ambient intelligence, Fashion accessories, Human–computer interaction, Internet of things, Ubiquitous computing, Health sciences, Wearable computer, Wearable technology, ERT, Clinical trial, Clinical endpoint

PHILADELPHIA, Feb. 25, 2021 /PRNewswire/ -- ERT , the global leader in clinical endpoint data collection, today released a new report, Innovation Frontiers in CNS Research , which analyzes the results of a recent industry survey on central nervous system (CNS) clinical trials.

Key Points: 
  • PHILADELPHIA, Feb. 25, 2021 /PRNewswire/ -- ERT , the global leader in clinical endpoint data collection, today released a new report, Innovation Frontiers in CNS Research , which analyzes the results of a recent industry survey on central nervous system (CNS) clinical trials.
  • The report reveals key challenges for sponsors and study teams, as well as the innovations they are implementing to address them, including wearable technologies and virtual trial solutions.
  • Current or planned use of wearables: 80% of survey respondents have used, or are planning to use, wearable technology in their CNS Trials.
  • Current adoption of virtual trial technologies in CNS trials: More than one third of respondents report running fully virtual, or decentralized, CNS trials or a hybrid model featuring some virtual solutions.

eClinical Solutions Expands West Coast Operations As Clinical Data Variety, Volume and Velocity Increase Industry-Wide

Retrieved on: 
Tuesday, February 23, 2021
Clinical data management, Clinical research, Medical research, Contract research organizations, Cloud infrastructure, Clinical trial management system, ERT, Cloud computing, Health sciences, Health

MANSFIELD, Mass., Feb. 23, 2021 /PRNewswire-PRWeb/ -- eClinical Solutions LLC , a leading global provider of cloud-based clinical data enterprise software and software-driven services, today announced the expansion of its West Coast team to support increased adoption of its flagship elluminate Clinical Data Platform .

Key Points: 
  • MANSFIELD, Mass., Feb. 23, 2021 /PRNewswire-PRWeb/ -- eClinical Solutions LLC , a leading global provider of cloud-based clinical data enterprise software and software-driven services, today announced the expansion of its West Coast team to support increased adoption of its flagship elluminate Clinical Data Platform .
  • Renewed investments in West Coast biotech clusters have resulted in life sciences companies in the region looking to work with providers that can deliver services in a more specialized, outsourced clinical operations model.
  • This environment is ideal for eClinical's ASCEND Data Services , which combine clinical data and biostatistics knowledge and expertise with modern technology platforms that offer increased control, quality and oversight to trial sponsors.
  • eClinical Solutions is a leading global provider of cloud-based enterprise software and software-driven clinical data services.

ERT Announces eCOA Multimedia, Enhancing Patient Data Capture with Photo and Audio in Clinical Trials

Retrieved on: 
Tuesday, February 23, 2021
Health sciences, Health, Clinical research, ERT, Medical research, Pharmaceutical industry, Clinical trial, E-research

This solution promises to streamline and drive patient compliance with data collection, while safeguarding patient privacy, confidentiality and data security.

Key Points: 
  • This solution promises to streamline and drive patient compliance with data collection, while safeguarding patient privacy, confidentiality and data security.
  • ERT's eCOA Multimedia solution allows patients to minimize site visits by enabling them to capture and send important files to the study's database from home.
  • Many clinical trials, like those in dermatology, skin cancer and CNS disorders require photos or audio to demonstrate the efficacy of new treatments.
  • ERT(eResearch Technology) is a global data and technology company that minimizes uncertainty and risk in clinical trials so that its customers can move ahead with confidence.

HealthPay24® Partners with Matrix Imaging Solutions to Bring a Collaborative Patient Experience to the Healthcare Industry

Retrieved on: 
Monday, February 22, 2021
ERT, UST, Health informatics

MECHANICSBURG, Pa., Feb. 22, 2021 /PRNewswire/ -- HealthPay24 and Matrix Imaging Solutions are partnering to strengthen their patient engagement processes in the healthcare industry.

Key Points: 
  • MECHANICSBURG, Pa., Feb. 22, 2021 /PRNewswire/ -- HealthPay24 and Matrix Imaging Solutions are partnering to strengthen their patient engagement processes in the healthcare industry.
  • HealthPay24, an all-in-one patient payment solution, will collaborate with Matrix Imaging, a healthcare communications company, to offer customers a stronger, more cohesive experience for their patients.
  • "Our partnership with Matrix Imaging Solutions allows us to offer our customers a comprehensive payment solution and better engagement model with patients.
  • www.healthpay24.com
    Matrix Imaging Solutions specializes in physical mail, automation, and electronic communications in the Healthcare Vertical.. By offering comprehensive, integrated solutions, Matrix improves your business efficiencies and maximizes your targeted growth.

Medical Device Outsourcing Market Size Worth $227.1 Billion By 2028: Grand View Research, Inc.

Retrieved on: 
Wednesday, February 10, 2021
Articles, Business, Economy, Offshoring, Economic globalization, International business, Business process, International trade, Outsourcing, Medical device, ERT

SAN FRANCISCO, Feb. 10, 2021 /PRNewswire/ -- The global medical device outsourcing market size is expected to reach USD 227.1 billion by 2028 registering a CAGR of 11.2%, according to a new report by Grand View Research, Inc.

Key Points: 
  • SAN FRANCISCO, Feb. 10, 2021 /PRNewswire/ -- The global medical device outsourcing market size is expected to reach USD 227.1 billion by 2028 registering a CAGR of 11.2%, according to a new report by Grand View Research, Inc.
  • Rising demand for advanced medical products is the key factor fueling the market growth.
  • For example, the European Medical Device Regulation undertakes special spontaneous inspection of outsourced products to test the quality as well as conformity with the standards.
  • Grand View Research has segmented the global medical device outsourcing market on the basis of service, application, and region:
    Medical Device Outsourcing Service Outlook (Revenue, USD Million, 2016 - 2028)

Medical Device Outsourcing Market Size Worth $227.1 Billion By 2028: Grand View Research, Inc.

Retrieved on: 
Wednesday, February 10, 2021
Articles, Business, Economy, Offshoring, Economic globalization, International business, Business process, International trade, Outsourcing, Medical device, ERT

SAN FRANCISCO, Feb. 10, 2021 /PRNewswire/ -- The global medical device outsourcing market size is expected to reach USD 227.1 billion by 2028 registering a CAGR of 11.2%, according to a new report by Grand View Research, Inc.

Key Points: 
  • SAN FRANCISCO, Feb. 10, 2021 /PRNewswire/ -- The global medical device outsourcing market size is expected to reach USD 227.1 billion by 2028 registering a CAGR of 11.2%, according to a new report by Grand View Research, Inc.
  • Rising demand for advanced medical products is the key factor fueling the market growth.
  • For example, the European Medical Device Regulation undertakes special spontaneous inspection of outsourced products to test the quality as well as conformity with the standards.
  • Grand View Research has segmented the global medical device outsourcing market on the basis of service, application, and region:
    Medical Device Outsourcing Service Outlook (Revenue, USD Million, 2016 - 2028)

IQVIA Recognized as Leading eCOA/ePRO Provider in Latest 2020 ISR eCOA/ePRO Market Report

Retrieved on: 
Thursday, February 4, 2021
Data management, Health, Technology, Software, Research, Science, Biotechnology, Contract research organizations, IQVIA, Science and technology, ERT, Computing, EPRO, Data management, Big data

IQVIA is honored to be recognized as one of the top eCOA providers in ISRs new 2020 eCOA/ePRO market report, which emphasizes the strength of our offering, said Rob Kotchie, president, Real World Solutions at IQVIA.

Key Points: 
  • IQVIA is honored to be recognized as one of the top eCOA providers in ISRs new 2020 eCOA/ePRO market report, which emphasizes the strength of our offering, said Rob Kotchie, president, Real World Solutions at IQVIA.
  • Were proud of the team for bringing this transformative new eCOA solution to market, ultimately helping sponsors to gather better insights faster and improve the patient experience globally.
  • IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry.
  • IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise.

Trialbee Announces the Release of HIVE, the Smartest Way to Leverage Real-World Data in Patient Recruitment

Retrieved on: 
Tuesday, February 2, 2021
Other Health, Software, Research, Pharmaceutical, Data management, Technology, Hospitals, Clinical trials, Science, Nanotechnology, Practice Management, Health, Health sciences, Life sciences, Health, Clinical research, Clinical trials, Pharmaceutical industry, Clinical data management, Clinical trial management system, Patient recruitment, High-performance Integrated Virtual Environment, ERT, RWD

Traditional patient recruitment has limited access to patients and takes a long time to accomplish.

Key Points: 
  • Traditional patient recruitment has limited access to patients and takes a long time to accomplish.
  • Trialbee HIVE is a result of combined expertise and close collaboration with Trialbee partner organizations specializing in global health research networks, RWD management, advanced data science techniques, consumer data connectivity platforms and eClinical technologies.
  • For more information on how HIVE can improve your trials patient recruitment and engagement, visit https://trialbee.com/platform/hive/ to schedule a demo .
  • Trialbee is a world leading technology provider in patient matching and engagement, empowering patients to participate in clinical trials as a care option.